FDA Inspection 1193365 — Piedmont Reproductive Endocrinology Group, Pa
The FDA completed an inspection of Piedmont Reproductive Endocrinology Group, Pa on Dec 6, 2022 in Greenville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 6, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Greenville, SC (United States)